[A case of Burkitt's lymphoma with maxillofacial involvement in an human immunodeficiency virus (HIV) seropositive Burundi young adult]. 1991

P Aubry, and A Bubahe, and V Bigirimana, and A Ndayiragije, and G Besnard, and A Bugambarara, and G Kamanfu
Département de Médecine interne du Centre Hospitalier Universitaire de Kamenge, Burundi.

A 30 years old African, heterosexual and HIV positive, was found with Burkitt's lymphoma (B.L.) localized on the maxillofacial area. The authors explain the rarity of the localization on the maxillo-facial area in temperate countries where Burkitt's lymphoma usually is multivisceral localized.

UI MeSH Term Description Entries
D008297 Male Males
D008339 Mandibular Neoplasms Tumors or cancer of the MANDIBLE. Mandibular Neoplasm,Neoplasm, Mandibular,Neoplasms, Mandibular
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D002063 Burundi A republic in eastern Africa bounded on the north by RWANDA and on the south by TANZANIA. Its capital is Bujumbura. Republic of Burundi,Urundi
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Aubry, and A Bubahe, and V Bigirimana, and A Ndayiragije, and G Besnard, and A Bugambarara, and G Kamanfu
December 1990, Ear, nose, & throat journal,
P Aubry, and A Bubahe, and V Bigirimana, and A Ndayiragije, and G Besnard, and A Bugambarara, and G Kamanfu
June 2001, International journal of cancer,
P Aubry, and A Bubahe, and V Bigirimana, and A Ndayiragije, and G Besnard, and A Bugambarara, and G Kamanfu
August 1994, Cancer,
P Aubry, and A Bubahe, and V Bigirimana, and A Ndayiragije, and G Besnard, and A Bugambarara, and G Kamanfu
September 2022, The Journal of the Association of Physicians of India,
P Aubry, and A Bubahe, and V Bigirimana, and A Ndayiragije, and G Besnard, and A Bugambarara, and G Kamanfu
July 2012, International journal of dermatology,
P Aubry, and A Bubahe, and V Bigirimana, and A Ndayiragije, and G Besnard, and A Bugambarara, and G Kamanfu
October 1987, Medicina clinica,
P Aubry, and A Bubahe, and V Bigirimana, and A Ndayiragije, and G Besnard, and A Bugambarara, and G Kamanfu
June 2012, Zhonghua bing li xue za zhi = Chinese journal of pathology,
P Aubry, and A Bubahe, and V Bigirimana, and A Ndayiragije, and G Besnard, and A Bugambarara, and G Kamanfu
August 1978, Missouri medicine,
P Aubry, and A Bubahe, and V Bigirimana, and A Ndayiragije, and G Besnard, and A Bugambarara, and G Kamanfu
December 2019, American journal of ophthalmology case reports,
P Aubry, and A Bubahe, and V Bigirimana, and A Ndayiragije, and G Besnard, and A Bugambarara, and G Kamanfu
March 1991, Journal of the National Cancer Institute,
Copied contents to your clipboard!